UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

The consensus sleep diary: standardizing prospective sleep self-monitoring

Sleep (New York, N.Y.), 2012-02, Vol.35 (2), p.287-302

2012

Volltextzugriff (PDF)

A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: The empirical basis for U.S. clinical practice

Sleep medicine reviews, 2009-08, Vol.13 (4), p.265-274

Krystal, Andrew D

2009

Volltextzugriff (PDF)

Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial

Lancet neurology, 2014-05, Vol.13 (5), p.461-471

2014

Volltextzugriff (PDF)

Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA

The American journal of psychiatry, 2017-01, Vol.174 (1), p.18-25

2017

Volltextzugriff (PDF)

International randomized-controlled trial of transcranial Direct Current Stimulation in depression

Brain stimulation, 2018-01, Vol.11 (1), p.125-133

2018

Volltextzugriff (PDF)

Obstructive Sleep Apnea and Incidence of Postoperative Delirium after Elective Knee Replacement in the Nondemented Elderly

Anesthesiology (Philadelphia), 2012-04, Vol.116 (4), p.788-796

2012

Volltextzugriff (PDF)

A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder

The journal of clinical psychiatry, 2007-02, Vol.68 (2), p.254

2007

Volltextzugriff (PDF)

Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 data

Psychopharmacology, 2017-06, Vol.234 (11), p.1703-1711

2017

Volltextzugriff (PDF)

Reducing Suicidal Ideation Through Insomnia Treatment (REST-IT): A Randomized Clinical Trial

The American journal of psychiatry, 2019-11, Vol.176 (11), p.957-965

2019

Volltextzugriff (PDF)

Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials

Biological psychiatry (1969), 2016-01, Vol.79 (2), p.136-148

2016

Volltextzugriff (PDF)

Long-Term Trazodone Use and Cognition: A Potential Therapeutic Role for Slow-Wave Sleep Enhancers

Journal of Alzheimer's disease, 2019-01, Vol.67 (3), p.911

2019

Volltextzugriff (PDF)

Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia

Sleep (New York, N.Y.), 2010-11, Vol.33 (11), p.1553-1561

2010

Volltextzugriff (PDF)

Optimizing computation of overnight decline in delta power: Evidence for slower rate of decline in delta power in insomnia patients

Clinical neurophysiology, 2021-02, Vol.132 (2), p.545-553, Article 545

2021

Volltextzugriff (PDF)

Comparison of diary-derived bladder and sleep measurements across OAB individuals, primary insomniacs, and healthy controls

International Urogynecology Journal, 2013-03, Vol.24 (3), p.501-508

2013

Volltextzugriff (PDF)

Pilot Prospective Study of Post-Surgery Sleep and EEG Predictors of Post-Operative Delirium

Clinical neurophysiology, 2017-08, Vol.128 (8), p.1421-1425

2017

Volltextzugriff (PDF)

Psychomotor performance deficits and their relation to prior nights' sleep among individuals with primary insomnia

Sleep (New York, N.Y.), 2008-05, Vol.31 (5), p.599-607

2008

Volltextzugriff (PDF)

Association of Sleep and β-Amyloid Pathology Among Older Cognitively Unimpaired Adults

JAMA network open, 2021-07, Vol.4 (7), p.e2117573

2021

Volltextzugriff (PDF)

Does physiological hyperarousal enhance error rates among insomnia sufferers?

Sleep (New York, N.Y.), 2013-08, Vol.36 (8), p.1179-1186

2013

Volltextzugriff (PDF)

Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials

Journal of clinical sleep medicine, 2016-09, Vol.12 (9), p.1215-1225

2016

Volltextzugriff (PDF)

Sustained efficacy of eszopiclone over 6 months of nightly treatment: Results of a Randomized, double-blind, placebo-controlled study in adults with chronic insomnia

Sleep (New York, N.Y.), 2003-11, Vol.26 (7), p.793-799

2003

Volltextzugriff (PDF)

An Electrophysiological Biomarker That May Predict Treatment Response to ECT

The journal of ECT, 2019-06, Vol.35 (2), p.95

2019

Volltextzugriff (PDF)

Longitudinal study of narcolepsy symptoms in first, second, and third-degree relatives of simplex and multiplex narcolepsy families

Sleep medicine, 2019-01, Vol.53, p.88-93

2019

Volltextzugriff (PDF)

A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Effect of Eszopiclone 2 mg on Sleep/Wake Function in Older Adults with Primary and Comorbid Insomnia

Sleep (New York, N.Y.), 2010-02, Vol.33 (2), p.225-234

2010

Volltextzugriff (PDF)

Changes in Seizure Threshold Over the Course of Electroconvulsive Therapy Affect Therapeutic Response and Are Detected by Ictal EEG Ratings

The journal of neuropsychiatry and clinical neurosciences, 1998-05, Vol.10 (2), p.178-186

1998

Volltextzugriff (PDF)

Sleep quality varies as a function of 5-HTTLPR genotype and stress

Psychosomatic medicine, 2007-09, Vol.69 (7), p.621-624

2007

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(53)

Sprache

Englisch
(53)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

Humans
(53)
Female
(48)
Life Sciences & Biomedicine
(47)
Male
(47)
Science & Technology
(47)
Middle Aged
(44)
Adult
(33)
Neurosciences & Neurology
(23)
Treatment Outcome
(22)
Clinical Neurology
(19)
Neurosciences
(17)
Aged, 80 And Over
(16)
Psychiatry
(15)
Biological And Medical Sciences
(14)
Medical Sciences
(14)
Sleep Initiation And Maintenance Disorders - Drug Therapy
(14)
Double-Blind Method
(13)
Insomnia
(13)
Electroconvulsive Therapy
(11)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The consensus sleep diary: standardizing prospective sleep self-monitoring

A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: The empirical basis for U.S. clinical practice

Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial

Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA

International randomized-controlled trial of transcranial Direct Current Stimulation in depression

Obstructive Sleep Apnea and Incidence of Postoperative Delirium after Elective Knee Replacement in the Nondemented Elderly

A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder

Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 data

Reducing Suicidal Ideation Through Insomnia Treatment (REST-IT): A Randomized Clinical Trial

Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials

Long-Term Trazodone Use and Cognition: A Potential Therapeutic Role for Slow-Wave Sleep Enhancers

Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia

Optimizing computation of overnight decline in delta power: Evidence for slower rate of decline in delta power in insomnia patients

Comparison of diary-derived bladder and sleep measurements across OAB individuals, primary insomniacs, and healthy controls

Pilot Prospective Study of Post-Surgery Sleep and EEG Predictors of Post-Operative Delirium

Psychomotor performance deficits and their relation to prior nights' sleep among individuals with primary insomnia

Association of Sleep and β-Amyloid Pathology Among Older Cognitively Unimpaired Adults

Does physiological hyperarousal enhance error rates among insomnia sufferers?

Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials

Sustained efficacy of eszopiclone over 6 months of nightly treatment: Results of a Randomized, double-blind, placebo-controlled study in adults with chronic insomnia

An Electrophysiological Biomarker That May Predict Treatment Response to ECT

Longitudinal study of narcolepsy symptoms in first, second, and third-degree relatives of simplex and multiplex narcolepsy families

A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Effect of Eszopiclone 2 mg on Sleep/Wake Function in Older Adults with Primary and Comorbid Insomnia

Changes in Seizure Threshold Over the Course of Electroconvulsive Therapy Affect Therapeutic Response and Are Detected by Ictal EEG Ratings

Sleep quality varies as a function of 5-HTTLPR genotype and stress

Aktive Filter

Suchergebnisse filtern